199 related articles for article (PubMed ID: 11684550)
41. High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report.
Rydzewska-Rosolowska A; Borawski J; Mysliwiec M
Adv Med Sci; 2009; 54(2):199-202. PubMed ID: 19758969
[TBL] [Abstract][Full Text] [Related]
42. Regional citrate anticoagulation for intermittent predilution online hemofiltration.
Gubensek J; Buturović-Ponikvar J; Skofic N; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):306-9. PubMed ID: 19695064
[TBL] [Abstract][Full Text] [Related]
43. Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study.
François K; De Clerck D; Tonnelier A; Cambier ML; Orlando C; Jochmans K; Cools W; Wissing KM
Am J Kidney Dis; 2022 Jan; 79(1):79-87.e1. PubMed ID: 33940113
[TBL] [Abstract][Full Text] [Related]
44. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
45. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
[TBL] [Abstract][Full Text] [Related]
46. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
Schneider M; Liefeldt L; Slowinski T; Peters H; Neumayer HH; Morgera S
Int J Artif Organs; 2008 Jan; 31(1):43-8. PubMed ID: 18286453
[TBL] [Abstract][Full Text] [Related]
47. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
[TBL] [Abstract][Full Text] [Related]
48. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
49. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
[TBL] [Abstract][Full Text] [Related]
50. Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis.
Opatrný K; Richtrová P; Polanská K; Wirth J; Sefrna F; Brandl M; Falkenhagen D
Artif Organs; 2007 Mar; 31(3):200-7. PubMed ID: 17343695
[TBL] [Abstract][Full Text] [Related]
51. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
Azar AT
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
[TBL] [Abstract][Full Text] [Related]
52. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
Kodras K; Benesch T; Neumann I; Haas M
Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
[TBL] [Abstract][Full Text] [Related]
53. Long-term citrate anticoagulation for high-flux haemodialysis in a patient with heparin-induced thrombocytopenia type II.
Unver B; Sunder-Plassmann G; Hörl WH; Apsner R
Acta Med Austriaca; 2002; 29(4):146-8. PubMed ID: 12424942
[TBL] [Abstract][Full Text] [Related]
54. Calcium exposure and removal in chronic hemodialysis patients.
Sigrist M; McIntyre CW
J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
[TBL] [Abstract][Full Text] [Related]
55. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.
Sagedal S; Hartmann A; Sundstrøm K; Bjørnsen S; Brosstad F
Nephrol Dial Transplant; 2001 May; 16(5):987-93. PubMed ID: 11328905
[TBL] [Abstract][Full Text] [Related]
56. Citrate anticoagulation and divalent cations in hemodialysis.
Janssen MJ; Huijgens PC; Bouman AA; Oe PL; van der Meulen J
Blood Purif; 1994; 12(6):308-16. PubMed ID: 7865189
[TBL] [Abstract][Full Text] [Related]
57. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.
Flanigan MJ; Pillsbury L; Sadewasser G; Lim VS
Am J Kidney Dis; 1996 Apr; 27(4):519-24. PubMed ID: 8678062
[TBL] [Abstract][Full Text] [Related]
58. Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis.
Thijssen S; Kossmann RJ; Kruse A; Kotanko P
Blood Purif; 2013; 35(1-3):133-8. PubMed ID: 23343558
[TBL] [Abstract][Full Text] [Related]
59. Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.
Kreuzer M; Ahlenstiel T; Kanzelmeyer N; Ehrich JH; Pape L
Pediatr Nephrol; 2010 Jul; 25(7):1305-10. PubMed ID: 20221775
[TBL] [Abstract][Full Text] [Related]
60. Regional sodium citrate anticoagulation in patients with active bleeding undergoing hemodialysis.
Ashouri OS
Uremia Invest; 1985-1986; 9(1):45-51. PubMed ID: 3835743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
